1. N Engl J Med 2002; 347:781-789 2. Journal of National Cancer Institute 2001; 93:1109 3. Cancer 2000; 88:1445 4. Prostate 1999; 38:83-91 5. J Clin Epidemiol 2002; 55:630 6. BMJ 2002; 325:737 7. Archives of Internal Medicine 1996; 156 :1333-36 8. Ann Intern Med 2002; 137:91799 9. Stamey TA. Journal Urol 2004; 172:1297-1301 10.McNaughton-Collins M et al. Am J Med 2004; 117:719-25 11. Thompson MI et al. Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower . JAMA. 2005 Jul 6;294:66-70 12. Concato J et al. The effectiveness of screening for prostate cancer: A nested case-control study. Arch Intern Med 2006 Jan 9; 166:38-43. 13. U.S. Preventive Services Task Force. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2008 Aug 5; 149.185-191 14. Lin K et al. Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force. Ann Intern Med 2008 Aug 5; 149: 192-199.
|
|
